AngioDynamics (NASDAQ:ANGO – Get Free Report) issued its quarterly earnings results on Wednesday. The medical instruments supplier reported $0.02 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.02, MarketWatch Earnings reports. The company had revenue of $91.10 million during the quarter, compared to the consensus estimate of $90.73 million. AngioDynamics had […]
AngioDynamics (NASDAQ:ANGO – Free Report) and NeuroPace (NASDAQ:NPCE – Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, earnings and valuation. Insider and Institutional Ownership 92.8% of AngioDynamics shares are held by […]
AngioDynamics (NASDAQ:ANGO – Free Report) and Titan Medical (NASDAQ:TMDIF – Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and dividends. Volatility & Risk AngioDynamics has a beta of 0.6, meaning […]
AngioDynamics (NASDAQ:ANGO – Free Report) and Titan Medical (NASDAQ:TMDIF – Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, institutional ownership, profitability, earnings and risk. Volatility & Risk AngioDynamics has a beta of 0.6, suggesting […]
AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) – Investment analysts at Zacks Research increased their Q4 2024 earnings per share (EPS) estimates for AngioDynamics in a report released on Tuesday, June 13th. Zacks Research analyst D. Dey now anticipates that the medical instruments supplier will earn $0.08 per share for the quarter, up from their previous […]